Hi, my name is Yoshiko Nakano, and I am a pediatric oncologist in Japan. Shinsuke Hirabayashi and I will join the YI committee for the upcoming 50th SIOP Congress in Kyoto. Today, we would like to write about some aspects of the current status of pediatric hematology/oncology in Japan.
This site uses cookies – small text files that are placed on your machine to help the site provide a better user experience. In general, cookies are used to retain user preferences, store information for things like shopping carts, and provide anonymised tracking data to third party applications like Google Analytics. As a rule, cookies […]
Website Terms of Use The website terms and conditions, together with the privacy policy (“Privacy Policy”) set out the terms of use on which you may make use of our website www.esgo.org (the “Site”), whether as a guest or a registered user (“Member”). Please read the Terms carefully. SIOP provides the Website to you, your employees, […]
Hi readers! My name is Francianne and I am a Ph.D. student in Brazil. Today I will discuss the particularities of epidemiologic research in my country and share the main findings of Brazilian studies on the epidemiology of childhood cancer.
Hi all. It is our great pleasure to introduce Jérémie Gaudichon, MD and PhD-to-be from France. He has agreed to write about work/life balance from a male perspective, and we are very grateful for his contribution to the blog.
Hello! My name is Liliana Vásquez, SIOP YI board member and today I would like to share some thoughts about telemedicine in cancer.
Today’s profile is of Ms. Laura Tan, who works at the VIVA-University Children’s Cancer Centre at the National University Hospital as an Outreach Program Senior Nursing Lecturer where she focuses on expanding Nursing Training in the Asia Pacific Region.
The next GHN Traditional and Complementary Medicine Working Group Meeting is scheduled for Wednesday, 29 May, 2024, at 12:00pm EST.
The role of the SIOP Epidemiology and Outcomes Network in the international pediatric oncology community is particularly valuable. Given the rarity of childhood cancers, international collaboration is crucial to sufficiently power epidemiologic and data-driven studies.